KEY POINTS
  • GlaxoSmithKline (GSK) has told around 2,500 staff in Britain to turn off a Covid-19 contact-tracing app while at work.
  • The pharmaceutical giant ordered employees at research and development labs and manufacturing facilities to switch off the Bluetooth contact-tracing feature that is built into the official Covid-19 app for England and Wales.
  • The app is seen as an integral part of the government's test and trace program.

In this article

View of the headquarters of the British pharmaceutical company GlaxoSmithKline in west London.

LONDON – U.K.-based drugmaker GlaxoSmithKline (GSK) has told around 2,500 staff in Britain to turn off a Covid-19 contact-tracing app while at work.

The pharmaceutical giant, which is working on a coronavirus vaccine, ordered employees at research and development labs and manufacturing facilities to switch off the Bluetooth contact-tracing feature that is built into the official Covid-19 app for England and Wales.

In this article